1. Home
  2. WST vs ERIE Comparison

WST vs ERIE Comparison

Compare WST & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ERIE
  • Stock Information
  • Founded
  • WST 1923
  • ERIE 1925
  • Country
  • WST United States
  • ERIE United States
  • Employees
  • WST N/A
  • ERIE N/A
  • Industry
  • WST Medical/Dental Instruments
  • ERIE Specialty Insurers
  • Sector
  • WST Health Care
  • ERIE Finance
  • Exchange
  • WST Nasdaq
  • ERIE Nasdaq
  • Market Cap
  • WST 15.6B
  • ERIE 17.9B
  • IPO Year
  • WST N/A
  • ERIE 1995
  • Fundamental
  • Price
  • WST $227.12
  • ERIE $346.18
  • Analyst Decision
  • WST Buy
  • ERIE
  • Analyst Count
  • WST 7
  • ERIE 0
  • Target Price
  • WST $331.67
  • ERIE N/A
  • AVG Volume (30 Days)
  • WST 646.1K
  • ERIE 152.2K
  • Earning Date
  • WST 07-24-2025
  • ERIE 07-24-2025
  • Dividend Yield
  • WST 0.37%
  • ERIE 1.58%
  • EPS Growth
  • WST N/A
  • ERIE 26.84
  • EPS
  • WST 6.37
  • ERIE 11.75
  • Revenue
  • WST $2,895,800,000.00
  • ERIE $3,903,813,000.00
  • Revenue This Year
  • WST $3.38
  • ERIE $11.70
  • Revenue Next Year
  • WST $5.85
  • ERIE $7.83
  • P/E Ratio
  • WST $35.63
  • ERIE $29.50
  • Revenue Growth
  • WST N/A
  • ERIE 14.91
  • 52 Week Low
  • WST $187.43
  • ERIE $332.34
  • 52 Week High
  • WST $352.33
  • ERIE $547.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • ERIE 45.92
  • Support Level
  • WST $219.60
  • ERIE $337.68
  • Resistance Level
  • WST $233.84
  • ERIE $355.18
  • Average True Range (ATR)
  • WST 5.29
  • ERIE 8.82
  • MACD
  • WST 0.60
  • ERIE 0.71
  • Stochastic Oscillator
  • WST 66.82
  • ERIE 53.29

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

Share on Social Networks: